Proximal Splenorenal Shunt in a Rare Renal Vein Anomaly: A Case Report.
left renal vein anomaly
ncph
proximal splenorenal shunt
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
25 May 2019
25 May 2019
Historique:
entrez:
1
8
2019
pubmed:
1
8
2019
medline:
1
8
2019
Statut:
epublish
Résumé
Left renal vein (LRV) has been considered as the most suitable vein for proximal splenorenal shunt (PSRS), a commonly performed shunt for non-cirrhotic portal hypertension. Anatomical anomalies in LRV that can pose technical difficulty during shunt procedure are reported in 10% cases. We report a rare anomaly of LRV which precluded performance of standard end-to-side proximal splenorenal shunt and describe its management by performing an interposition end-to-end proximal splenorenal shunt. A 50-year-old female presented with recurrent episodes of upper gastrointestinal bleed for five years. She was pale and had a massive splenomegaly. There were no signs of encephalopathy. Upper gastrointestinal (UGI) endoscopy revealed three columns of grade 3 esophageal varices, large fundal varices and mild portal hypertensive gastropathy. Duplex ultrasound and contrast-enhanced computed tomography (CECT) of the abdomen was suggestive of non-cirrhotic portal fibrosis. She underwent an interposition end-to-end proximal splenorenal shunt with inferior branch of left renal vein. She developed partial shunt thrombosis at follow-up of 18 months and underwent balloon angioplasty and metallic stenting of shunt. She is doing well at 24 months follow-up with no recurrence of symptoms and a patent shunt. In conclusion, the presence of renal vein abnormalities does not preclude performance of PSRS with suitable modifications. A high index of suspicion is required to detect them preoperatively to avoid technical difficulties and to plan modifications of PSRS. Interposition end-to-end graft proximal splenorenal shunt is a valid option with good primary-assisted patency rate and clinical outcome.
Identifiants
pubmed: 31363436
doi: 10.7759/cureus.4754
pmc: PMC6663117
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e4754Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Am J Surg. 1975 May;129(5):503-5
pubmed: 1079408
Anat Cell Biol. 2012 Mar;45(1):57-61
pubmed: 22536553
Rom J Morphol Embryol. 2014;55(1):77-81
pubmed: 24715169
BMC Surg. 2017 Jun 2;17(1):65
pubmed: 28576121
Ann Surg. 1994 Feb;219(2):193-6
pubmed: 8129490